News

Biomerica Advances with Patents and Market Expansion Plans

Biomerica Advances with Patents and Market Expansion Plans

Biomerica Makes Significant Patent Progress in Europe

Biomerica, Inc. (NASDAQ: BMRA), a pioneering biomedical technology firm, has recently announced the positive reception of three patent notices from the European Patent Organization (EPO). These patents focus on innovative technologies and methods for treating common gastrointestinal disorders, specifically Gastroesophageal Reflux Disease (GERD), Crohn’s Disease, and Ulcerative Colitis, utilizing the unique inFoods® Technology developed by the company.

The Scope of Biomerica's Patents

This exciting development encompasses numerous countries across Europe within the EPO, including Germany, the UK, France, Italy, Spain, among many others. Collectively, these patents are geared towards providing tailored solutions to manage these gastrointestinal challenges, targeting a noteworthy market potential exceeding $8 billion across the continent.

What is inFoods® Technology?

Biomerica's inFoods® Technology stands out as a diagnostic-guided therapeutic approach that identifies individual dietary triggers for patients. This personalized methodology may significantly diminish reliance on traditional medications that often carry harsh side effects. For example, patients suffering from GERD can look towards inFoods® as a viable option in place of proton pump inhibitors (PPIs), which are associated with serious health issues like dementia and kidney disease.

Market Strategy and Future Developments

Currently, Biomerica is actively marketing the inFoods® test tailored for individuals with Irritable Bowel Syndrome (IBS) and is well-protected with 15 existing patents globally. The new patents received from the EPO will further bolster Biomerica’s ability to expand its development of therapeutic products across a wider spectrum of gastrointestinal conditions.

Leadership Insights

Zack Irani, the CEO of Biomerica, expressed his enthusiasm over the development, noting that the inFoods® strategy signifies a substantial evolution in gastrointestinal healthcare prioritizing personalized, drug-free treatments. The successful receipt of these patents aligns with Biomerica's ongoing commitment to enhancing patient outcomes while diversifying its gastrointestinal solutions.

Steps Towards Patent Issuance

The progression toward patent issuance in the various EPO jurisdictions hinges on Biomerica completing essential steps, including settling necessary fees associated with patent issuance. The company may decide to target specific countries within the EPO for patent issuance, based on strategic interests, rather than pursuing patents in every eligible country.

Focus on Health and Cost Efficiency

Biomerica's primary mission emphasizes addressing gastrointestinal and inflammatory diseases through innovative diagnostic and therapeutic products that not only aim to improve overall health but also contribute to lowering healthcare expenses.

Recent News and Developments

In addition to its patent news, Biomerica has recently secured a 180-day extension from Nasdaq, allowing the company additional time to meet minimum bid price requirements for continued listing on the Nasdaq Capital Market. With this extension, the company can reassess its strategies up until May 2025, ensuring compliance with all other listing prerequisites.

Strategic Product Developments

Biomerica has made notable strides in product innovations, with recent approvals for its Fortel® Prostate (PSA) Screening Test from the Saudi Food and Drug Authority, indicating its expanding presence in international markets such as the Middle East. Additionally, a pilot program for the inFoods IBS product is currently underway, alongside an exclusive multi-year distribution agreement established for its at-home cancer screening products in the United Arab Emirates.

Looking Ahead

Furthermore, Biomerica has broadened its operational footprint across the United States, highlighting its aim to enhance service delivery. The company has also successfully acquired five additional patents relating to its inFoods technology in regions such as Europe, Canada, and Japan.

In an announcement concerning leadership changes, the company reported the immediate resignation of its Board Chairman, Jack Kenny, citing personal reasons. A succession plan is currently in development to identify his successor.

Frequently Asked Questions

What are the primary focus areas of Biomerica?

Biomerica specializes in gastrointestinal and inflammatory diseases, developing innovative diagnostic and therapeutic solutions.

What is inFoods® Technology?

inFoods® Technology is a personalized diagnostic-guided therapy that identifies food triggers in patients, aiming to reduce medication use.

What recent patents has Biomerica secured?

Biomerica has received patents for methods to treat GERD, Crohn’s Disease, and Ulcerative Colitis in Europe.

What steps does Biomerica need to complete for its patents?

The company must fulfill necessary steps such as paying patent issuance fees to complete the patent process in EPO countries.

How has Biomerica performed in the stock market recently?

Biomerica has received an extension from Nasdaq due to challenges in maintaining its minimum bid price requirement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 136

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 187

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
PenFed Fuels Aggie Spirit with Blackout Game Activation

Updated Category News Views 196

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 115

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading
ACME's AI Innovation Shakes Up Filmmaking Scene

Updated Category News Views 87

The Game-Changer in Virtual Production You ever hear about the Grey Box™ phenomenon? Sounds like a sci-fi gizmo, right? Turns out, it's the real deal and ACME Media's been riding this revolutionary wave straight to the top of the film industry ladder. Their approach with this AI-driven gizmo isn't just about cutting-edge tech wizardry—it's reimagining how we shoot...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 163

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 139

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Terra Kaffe's Big Win with Oprah's Endorsement

Updated Category News Views 109

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Continue Reading
Shorenstein Expands in Dallas: Strategic Play or Risk?

Updated Category News Views 127

Shorenstein's recent acquisition of International Plaza 3 isn't just about adding another high-rise to their portfolio; it's a stake in the ground, a doubling down on the Dallas real estate market. With its aim sharply set on the Lower Tollway submarket, Shorenstein is showing confidence, but the big question remains—are they spot on or walking the razor's edge?...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 60

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

The Brattle Group Enhances Services with New Principal

Updated Category News Views 168

The Brattle Group Enhances Services with New Principal The Brattle Group is pleased to announce the addition of Hans Weemaes as a Principal in its Financial Services & Markets and Regulatory Investigations & Enforcement practices. With an impressive background as a former economist for a federal treasury, Mr. Weemaes carries over 20 years of extensive experience in...

Continue Reading
Lumen and AWS Unite to Advance Generative AI Through Networks

Updated Category News Views 263

Lumen and AWS Join Forces in Generative AI Development Lumen Technologies (NYSE: LUMN) has announced a strategic collaboration with Amazon Web Services (AWS), an Amazon.com company (NASDAQ: AMZN), aiming to enhance network operations and delivery capabilities. This partnership is set against the backdrop of expanding AI-driven services that demand efficient and robust...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 46

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Modernization: Strengthening Ties Between China and Africa

Updated Category News Views 64

Modernization: Strengthening Ties Between China and Africa Recently, China Everything released an engaging short video titled "A shared path to modernization." This video highlights the successful collaboration between China and Africa, showcasing the strong friendship that has developed between the people of these two regions. The Unity of Aspirations As the largest...

Continue Reading
Okeanis Eco Tankers Announces Dividend Details for Shareholders

Updated Category News Views 129

Okeanis Eco Tankers Declares Dividend for Common Shares Okeanis Eco Tankers Corp. (NYSE: ECO / OSE: OET) has announced a significant dividend for its shareholders. The board of directors has officially declared a dividend on its common shares, representing a fruitful opportunity for investors as they participate in the company's success. This dividend is a reflection of...

Continue Reading